Explore the transformative potential of epigenetics in diagnostics. This session highlights how advanced epigenetic technology can analyze over 1,600 biomarkers from a single drop of blood, offering insights into chronic disease prevention, aging, and personalized health strategies. Learn how these innovations can reduce costs, increase precision, and revolutionize healthcare by enabling early disease detection and tailored interventions.
Learning Objective #1: Understand the principles of epigenetics and how DNA methylation biomarkers provide predictive and precise data about health and disease.
Learning Objective #2: Evaluate the advantages of epigenetic diagnostics over traditional methods, including cost-effectiveness, ease of collection, and improved predictive capabilities.
Learning Objective #3: Discover practical applications of epigenetic biomarkers in diagnosing chronic diseases, optimizing health outcomes, and enhancing personalized healthcare strategies.
Dr. Matthew Dawson is the founder and CEO of Wild Health, a genomics based precision medicine company, and the CEO of TruDiagnostic, an epigenetics testing lab. He has authored two textbooks, published over 2 dozen studies, lectured in over 20 countries, and won national awards for education and innovation. His passion is unlocking the secrets of the genome and epigenome and using it to optimize health and maximize healthspan. He lives in the woods with his wife, 4 children, and two dogs.
Explore our portfolio of official integrative healthcare media, publications, and events.
